Information and Communication Technology (ICT)- Based Centralized Monitoring System of Asthma Control

Yeungnam University Hospital

Status: Unknown

Conditions: Asthma

Treatments: Device: Feedback using ICT based monitoring system

Study type: Interventional

Funder types: Other

Identifiers

NCT03327363

ICT-RTM-P06 Asthma

Details and patient eligibility

About

The aims of this study is to evaluation of the clinical efficacy and stability of Information and Communication Technology (ICT)- based centralized monitoring system of asthma control monitoring in asthma patients. We planed to enroll 100 asthma patients (50 subjects using ICT systems, 50 controls). We will monitor the asthma control status, lung function, exacerbation rate and stability of ICT systems.

This study is based upon work supported by the Ministry of Trade, Industry & Energy (MOTIE, Korea) under industrial Technology Innovation Program (No. 10059066, 'Establishment of ICT Clinical Trial System and Foundation for Industrialization').

Full description

This study has a multi- center, open- label, prospective and randomized clinical trial design. One hundred asthma patients who fill out the informed consent form are registered and randomized 1:1 into the ICT-based centralized clinical trial monitoring group (n=50) or the ambulatory follow-up group (n=50). The planned follow-up duration is 6 months. he ICT-based centralized clinical trial monitoring group is given home based spirometry and connecting system (gateway) equipped with personal identification system. Fingerprint registration is required in advance, so that it would be used for authentication before each use of spirometry. Symptom score and lung functions (FEV1, PEFR) obtained from gateway is saved, monitored, and sent out via a home-monitoring system. In the ICT-based centralized clinical trial monitoring group, feedback is sent to both patients and medical staff in the form of texts if there is a worsening of symptoms score and/or lung function.

Subjects are to make office visits after randomization at 4, (8), 12, (16, 20), and 24 weeks. (ICT group will not visit at the schedules in the brackets) Each visit requires measurement of Questionnaire (ACQ) lung functions.

Enrollment: 100 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• asthma patients diagnosed by doctors
• Current treatment with Inhaled corticosteroid or leukotriene receptor antagonist
• able to give written informed consent prior to participation in the study

Exclusion criteria

• Subjects with plan of administration or operation within study periods
• Unstable heart disease and psychical disorder
• refuse the monitoring

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups, including a placebo group

ICT base monitoring group

Experimental group

Description:

In the ICT-based centralized monitoring group, both subjects and medical staff receive feedback regarding decreased lung function and exacerbation in asthma symptoms in the form of text messages

Treatment:

Device: Feedback using ICT based monitoring system

control group

Placebo Comparator group

Description:

Use standard asthma treatment

Treatment:

Device: Feedback using ICT based monitoring system